Novotech, a globally recognized full-service biotech specialist clinical research organization (CRO), announced today that ...

The two sovereign wealth funds have taken a “significant stake” in the clinical research business owned by the private equity ...

Existing investor TPG will also reinvest in Novetech through its TPG Asia fund, Novotech announced in a press statement posted on its website.

SINGAPORE] Clinical research and testing provider Novotech on Monday (Mar 31) announced that Temasek and GIC will acquire a ...

Since TPG’s investment in 2017, the firm has raised its headcount tenfold to 3,000 employees and expanded its operations ...

Temasek and GIC will acquire a significant stake in Novotech, whose ebitda has grown fivefold since TPG’s initial investment ...

Temasek Holdings Pte and GIC Pte Ltd. will acquire a significant stake in Novotech Pty Ltd. to fuel growth and accelerate ...

The reinvestment by TPG Asia and investment from GIC and Temasek will allow Novotech to pursue further organic growth and ...

SYDNEY--(BUSINESS WIRE)--Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company that provides biotech and small- to mid-sized pharma ...

SYDNEY, March 27, 2025--(BUSINESS WIRE)--Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company, has released its newest preclinical ...

Novotech, a globally recognized full-service biotech specialist clinical research organization (CRO), announced today that affiliates of GIC and Temasek have signed binding agreements to acquire a ...

Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company, has released its newest preclinical report exploring the evolving landscape of small ...